Home/Database/Cerebrolysin
NootropicApproved (45+ countries)

Cerebrolysin

Porcine Brain-Derived Peptide Mixture

Amino Acids

N/A

Molecular Weight

Mixture (< 10,000 Da)

Half-life

~minutes to hours

Research Score

4.6

Studies

245

Storage

N/A

What is Cerebrolysin?

Cerebrolysin is a mixture of low-molecular-weight neuropeptides and free amino acids derived from porcine brain tissue. It has neurotrophic properties similar to naturally occurring nerve growth factors. Approved in many countries for stroke recovery, traumatic brain injury, and dementia.

Key Benefits & Mechanisms

Neurotrophic factor-like activity

Neuroprotection in stroke and TBI

Improved cognitive function in dementia

Promotes neuronal survival and plasticity

Reduces amyloid pathology

Enhanced recovery from brain injuries

Synaptic repair and neurogenesis

Research Summary

Cerebrolysin has extensive clinical evidence with over 200 clinical studies. Approved in more than 45 countries for neurological conditions. Cochrane reviews show moderate evidence for vascular dementia. Large-scale trials (CARS, CASTA) demonstrate benefits in stroke recovery.